ENT Balloon Dilation Device Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Balloon Sets

ENT Balloon Dilation Device Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Balloon Sets

The global market for ENT balloon dilation devices had a valuation of $933 million in 2022, and it is expected to grow at a CAGR of 3.9% during the forecast period, reaching $1.2 billion. The comprehensive report focuses on the balloon sets and excludes the extended set of the market.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL ENT BALLOON DILATION DEVICE MARKET INSIGHTS

The one-sitting, minimally invasive nature of the procedure is a significant driver of the ENT balloon dilation device market. Patients typically experience minimal bleeding and can return to their normal routine within a few hours, making the procedure highly appealing. As a result, these devices have gained popularity worldwide.

GLOBAL ENT BALLOON DILATION DEVICE MARKET SHARE INSIGHTS

The Global ENT balloon dilation device market was led by Acclarent, Stryker, and Medtronic.
Acclarent was the pioneer competitor in the market for balloon sinus dilation (BSD) devices with the launch of its Relieva® Balloon Sinuplasty system. Acclarent's acquisition by Johnson & Johnson in 2010 provided the company with the necessary sales and marketing resources to compete in this rapidly expanding market. Acclarent owes much of its current success to its early entry into this market and its affiliation with Johnson & Johnson.

MARKET SEGMENTATION SUMMARY

ENT Balloon Dilation Device Market – MedCore – Includes:
Balloon Sets

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.